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Cardiac Over-Expression of Creatine Kinase Improves Function in Failing
Myocytes
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Aims: Abnormal energy metabolism contributes to heart failure (HF) and the
failing heart is energy starved. Here we tested whether augmented CK energy
metabolism improves myocyte dysfunction in experimental HF.
Methods and Results: We tested the response to the b-agonist isoproterenol
(2.5 nM, ISO) in cardiomyocytes isolated from wild-type (WT) mice and
mice over-expressing cardiac myofibrillar and mitochondrial CK (CK-M
and CK-mito) from sham and HF (8 wk transverse aortic constriction,
TAC) hearts, to dissect whether over-expressing CK-M or CK-mito might
alter myocyte function at baseline or after an increase in energetic demand.
At baseline, there were no differences in sarcomere fractional shortening
(FS) or whole Ca2þ transient amplitude in response to ISO among sham
WT, CK-M or CK-mito myocytes. However, ISO impact on FS, Ca2þ tran-
sient, time to 50 Ca2þ decay, and sarcomere re-lengthening were all reduced
in WT TAC hearts, consistent with prior reports. Conversely, over-expressing
CK-M or CK-mito rescued ISO-induced inotropy in TAC myocytes. No
sizable differences in ISO response were noticed in cells obtained from
sham WT, CK-M or CK-mito hearts. To test whether over-expressing
CK-M or CK-mito confers a degree of protection against acute oxidative
stress, non-TAC myocytes were exposed to H2O2 (50 mM for 10 min). The
interval between the beginning of H2O2 superfusion and the appearance of
an irreversible arrhythmia was measured. WT and CK-M myocytes showed
a similar response (359587s vs. 370560s, n¼5), whereas in CK-mito this
interval was prolonged (580574s).
Conclusions: Over-expressing CK-M and CK-mito under failing-TAC condi-
tions improves myocyte contraction and relaxation, likely through preserved
Ca2þ handling; however, only the up-regulation of CK-mito can effectively
buffer ROS, especially those of mitochondrial origin.
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Acute Ablation of Cardiac Myosin Light Chain Kinase Decreases Cardiac
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Cardiac myosin light chain kinase (cMLCK) phosphorylates a single site in the
regulatory light chain (RLC) of myosin to increase Ca2þ sensitivity of myofil-
ament contractions. A constellation of contractile protein phosphorylations in
addition to RLC phosphorylation fine-tune actin-myosin myofibrillar force
development to modulate cardiac performance. In the normal beating heart
RLC is significantly phosphorylated (~45%) which may play a constitutive
physiological role to enhance cardiac performance. Conventional cMLCK
knockout mice have dilated hearts with severely compromised cardiac perfor-
mance at 10 weeks of age and older. To determine if the dilated phenotype
caused by cMLCK knockout is preceded by a loss of cardiac performance
associated with decreased phosphorylation of RLC and other myofibrillar pro-
teins, we generated an acute model for the conditional knockout of cMLCK.
We optimized the minimal amount of tamoxifen necessary for cMLCK ablation
and assessed cardiac performance measured as fractional shortening by echo-
cardiography. Hearts were then harvested for analyses of protein contents
and phosphorylations. Five consecutive daily i.p. injections of 0.5 mg tamox-
ifen per mouse were sufficient to reduce cMLCK 8052% by two weeks after
the first tamoxifen injection. RLC phosphorylation was reduced to 1552%
while left ventricular internal diameter at end-diastole significantly increased
by 1.450.3 mm and fractional shortening decreased 4756%. There was no ev-
idence of compensatory hypertrophy. Troponin-I and myosin binding protein-C
phosphorylation at Ser23/24 and Ser282, respectively, did not significantly
change. Both phosphorylations were reduced with propranolol treatment,
which had no effect on RLC phosphorylation. These results suggest that consti-
tutive RLC phosphorylation contributes to cardiac performance in the normal
beating heart.3001-Pos Board B431
Cardiac Remodeling in the Mouse Model of Marfan Syndrome Develops
Independently from Aortic and Valvular Abnormalities
Natalia Petrashevskaya, Hyun-Jin Tae, Shanon Marshall,
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Marfan syndrome (MFS) is a multisystem disorder of connective tissue caused
by mutations in fibrillin-1. Heart involvement in the Marfan syndrome patients
includes aortic root dilatation, valvular insufficiency, and myocardial dys-
function; it remains unclear, however, whether alterations in myocardium are
triggered by valvular and aortic pathology or they develop independently.
We evaluated the age-dependent cardiac remodeling and left ventricular
dysfunction in the mouse model of MFS known as Fbn1039Gþ/mouse (Mar-
fan HT mouse) using echocardiography, pressure-volume loop analyses and a
number of histological and biochemical techniques.
Marfan HT mice of 2-4 month demonstrated a hypertrophic cardiac remodeling
accompanied by predominant decline of diastolic function and increased TGF-b
canonical (p SMAD2/3) and non-canonical (pERK½ and pMAPK38) signaling.
Hypertrophic myocardium among older HT mice (6-14 months) was associated
with two distinctly different phenotypes manifesting either dilated or constricted
LV chamber. Dilatation of LV chamber was accompanied by biochemical evi-
dence of greater mechanical stress, including elevated ERK1/2 phosphorylation
and brain natriuretic peptide expression in comparison with constricted heart.
Diastolic dysfunction in the older HT mice was combined with significant sys-
tolic impairment. The aortic valve regurgitation was registered in 20% of con-
stricted group and 60% of dilated, while mitral insufficiency was observed in
40% of constricted group and 100% of dilated. InMarfan HTmice, extracellular
matrix abnormalities were not associated with the increase of interstitial fibrosis
and non-myocyte proliferation. In the mouse model of fibrillin-1 haploinsuffi-
ciency the early onset of hypertrophic cardiac remodeling and dysfunction is
not consequent to functional valvular abnormalities, but it is likely to result
from deficient mechanosensing and transmission of mechanical forces.
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Transgenic Over-Expression of Carbonic Anhydrase III in Cardiac
Muscle Demonstrates a Mechanism to Resist Acidosis
Hanzhong Feng, Jian-Ping Jin.
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Carbonic anhydrase III (CAIII) is an abundant protein in skeletal muscle, liver
and adipose cells. A cytosolic enzyme that catalyzes conversions between CO2
and HCO3
- in regulating intracellular pH, its physiological function in muscle is
unclear. Mice lacking CAIII showed lower than wild type intracellular pH in
skeletal muscle cells during fatigue treatment. To further understand the role
of CAIII in muscle functions and stress adaptation, we developed transgenic
mice overexpressing CAIII in the heart under the control of a cloned myosin
heavy chain promoter for phenotype comparisons with wild type mouse hearts
that are CAIII negative. Three months old transgenic mice showed normal car-
diac phenotypes under non-stress conditions. Cardiac function was examined
using ex vivo working heart preparations under normal and low pH conditions
to investigate CAIII function in pH regulation of cardiac muscle. With equili-
bration of 5% CO2 generating pH 7.4 in normal Kreb’s perfusion buffer, 10%
CO2 was used to lower pH to 7.0. Functional data showed that transgenic and
wild type hearts had similar pumping functions under normal pH. Perfused with
low pH buffer, heart functions of both groups were decreased. In comparison
with wild type controls at low pH, CAIII transgenic mouse hearts showed
higher left ventricular pressure development and systolic and diastolic veloc-
ities under both baseline conditions and increased afterload stress, indicating
a better tolerance to acidosis. The results suggest that CAIII may function in
compensating for intracellular pH under acidotic conditions, a tractive novel
approach to develop new treatment of chronic congestive heart failure.
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Myocardial Interstitial Serotonin and its Major Metabolite, 5-Hydroxyin-
dole Acetic Acid Levels Determined by Microdialysis Technique in vivo
Rat Heart
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Aims: The aim of this study was to elucidate myocardial interstitial serotonin
(5-HT) kinetics in the heart, including 5-HT reuptake and enzymatic degrada-
tion to 5-hydroxyindole acetic acid (5-HIAA) via monoamine oxidase (MAO).
Main methods: Using microdialysis technique in anaesthetized rats, we simulta-
neouslymonitoredmyocardial interstitial levels of 5-HT and its major metabolite,
5-HIAA, in the left ventricle and examined the effects of local administration of a
MAO inhibitor, pargyline, or a 5-HT uptake inhibitor, fluoxetine.
596a Wednesday, February 11, 2015Key Findings: Pargyline increased dialysate 5-HT concentration from 1.85 0.3
at baseline to 3.95 0.5 nM but decreased dialysate 5-HIAA concentration from
20.75 1.0 at baseline to 15.85 1.4 nM at 60-80 min of administration. Fluox-
etine increased dialysate 5-HT concentration from 1.95 0.4 at baseline to 6.55
0.9 nM at 60-80 min of administration, but did not change dialysate 5-HIAA
concentration. Local administration of ADP (100 mM) increased dialysate 5-
HT and 5-HIAA concentrations. Pargyline did not affect ADP-induced increase
in dialysate 5-HT concentration but suppressed ADP-induced increase in dialy-
sate 5-HIAA concentration during 60 min of ADP administration. Fluoxetine
increased dialysate 5-HT concentration at 40-60 min of ADP administration,
but did not affect ADP-induced increase in dialysate 5-HIAA concentration.
Significance: Simultaneous monitoring of myocardial interstitial 5-HT and
5-HIAA levels provides valuable information on 5-HT kinetics including reup-
take and enzymatic degradation by MAO, which play a role in the regulation
of myocardial interstitial 5-HT levels at baseline and when 5-HT levels are
elevated.
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The therapeutic effect of ghrelin has been reported in humans as well as in an-
imal models of chronic heart failure. However, little is known about the thera-
peutic efficacy of ghrelin for the treatment of inherited forms of dilated
cardiomyopathy (DCM). We aim to examine whether ghrelin is beneficial for
the treatment of inherited DCM with a deletion mutation DK210 in the cardiac
troponin T (cTnT) gene using a knock-in mouse model. Ghrelin (150 mg/kg/day)
was administered subcutaneously to the mouse model of inherited DCM.
The therapeutic effects were examined on the basis of survival and myocardial
remodeling. Ghrelin administration prolonged the life span of DCM mice
compared to the saline-treated controls. Echocardiography data showed that
ghrelin reduced left ventricular (LV) end-diastolic dimensions and increased
LV ejection fraction. Moreover, histoanatomical data revealed that ghrelin
decreased the heart-to-body weight ratio, prevented cardiac remodeling and
fibrosis, and markedly decreased the expression of brain natriuretic peptide.
Telemetry recording and heart rate variability analysis showed that ghrelin sup-
pressed the excessive cardiac sympathetic nerve activity (CSNA) and recovered
the cardiac parasympathetic nerve activity. Ghrelin has therapeutic benefits for
the treatment of DCMwith DK210 mutation in cTnT. Importantly, these cardio-
vascular benefits of ghrelin are likely linked to the suppression of CSNA and
recovery of cardiac parasympathetic nerve activity.
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Causes Dose-Dependent Effects on Cardiac Function and Remodeling in
Transgenic Mice
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O. Lynne Nelson3, Dan B. Rodgers2, Murali Chandra1.
1Dept of Integrative Physiology and Neuroscience, Washington State
University, Pullman, WA, USA, 2School of Molecular Biosciences,
Washington State University, Pullman, WA, USA, 3Internal Medicine and
Cardiology, Veterinary Teaching Hospital, Washington State University,
Pullman, WA, USA.
The N-terminal extension (NTE; residues 42-73) of mouse cardiac troponin T
(TnT) desensitizes cardiac myofilaments to Ca2þ by stabilizing thin filaments
in the blocked-state.We arrived at this conclusion using detergent-skinnedmus-
cle from transgenic (TG)mouse hearts that expressed 54%of chimeric TnT (res-
idues 1-73 of mouse cardiac TnT were replaced by residues 1-41 of mouse fast
skeletal TnT). Here, we extended our investigation to include higher dose effects
of the modified TnT on cardiac myofilament function/phenotype using
detergent-skinned fiber studies and echocardiography measurements in two
different TG mouse lines (TG-55 and TG-64 that expressed 55% and 64% of
chimeric TnT, respectively). Both TG-55 and TG-64 mice showed a similar in-
crease in myofilament Ca2þ sensitivity at sarcomere lengths (SL) of 1.9 and 2.3
mm. However, Ca2þ-activated maximal tension increased significantly only in
TG-64 mice at either SL. There was a progressive decrease in the overall heartsize andheart-to-bodyweight ratios in bothTG-55 andTG-64mice. Left ventric-
ular diastolic functional parameters (isovolumic relaxation time and E-wave
deceleration time) showed a graded increase in TG-55 and TG-64 mice; how-
ever, such effects were only significant in TG-64 mice, suggesting impaired
relaxation. Systolic functional parameters (stroke volume, ejection fraction
and fractional shortening) were unaffected in TG-55 mice, but significantly
decreased in TG-64 mice. Thus, higher levels of chimeric TnT (64%) depressed
both diastolic and systolic function significantly in TG-64mice.Wewill discuss
the link between the effects of the modified N-terminus of TnT on cardiac
myofilament function and the resultant pathological remodeling of the heart.
Our findings have pathological relevance because a growing number of
disease-related mutations are found both in and near the NTE of cardiac TnT.
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Functional Effects of the H1-Helix of Rat Cardiac Troponin T on Cross-
bridge Detachment Rate is Differently Modulated by a- and b-Myosin
Heavy Chain Isoforms
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The primary structure of the H1-helix of troponin T (TnT) varies among different
types of striated muscles. Moreover, these muscles also express different myosin
heavy chain (MHC) isoforms. Recently, we demonstrated that pseudo-phosphor-
ylation of residue 204 (near the H1-helix) of cardiac TnT affected the functional
state of the thin filament differently in fibers that expressed either a- or b-MHC
isoforms (Michael et al., Basic Res Cardiol, 109:442, 2014). In this follow-up
study, we investigated how the isoform-specific function of the H1-helix of car-
diac TnT was influenced by a- and b-MHC isoforms. We generated a mutant
rat cardiac TnT (RfsH1) in which the cardiac H1-helix was replaced by the fast
skeletal H1-helix. Recombinant RfsH1 was reconstituted into detergent-skinned
cardiac muscle fibers from either normal rats (expressing a-MHC) or propylth-
iouracil treated rats (expressing b-MHC). Steady-state and dynamic measure-
ments were carried out at sarcomere length 2.3 mm. Our results demonstrated
that RfsH1 decreased Ca2þ-activated maximal ATPase activity differently in
a-MHC (~33%) and b-MHC (~17%) fibers. Furthermore, RfsH1 decreased ten-
sion cost (~31%) and crossbridge (XB) distortion dynamics (~25%) in a-MHC
but not in b-MHC fibers. Because the above mentioned parameters are indices
of the rate of XB detachment, our results suggest that the interplay between the
RfsH1- and a-MHC-mediated effects on the thin filament modulates XB detach-
ment kinetics. Our findings suggest that the conformational changes in the H1-
helix of TnT are sensitive toMHC isoform-mediated changes in the thin filament.
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Engineering Cardiac Troponin C: Potential Therapeutic for Heart Failure
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We have engineered cardiac TnCs with increased (L48Q) or decreased (D73N)
Ca2þ sensitivity. To express these proteins in the in vivo heart we utilized an
adeno-associated virus serotype 9 (AAV-9). The Ca2þ desensitized D73N
TnC recapitulated a dilated cardiomyopathy phenotype and depressed function
as observed by echocardiography and isolated cardiomyocytes. On the other
hand, AAV-9 containing the Ca2þ sensitized L48Q TnC did not cause any
disease phenotype or arrhythmias commonly associated with increased myofil-
ament Ca2þ sensitivity. In healthy mice, L48Q TnC increased myocyte contrac-
tion and whole heart contractility with improved cardiovascular performance
(increased V02max). Excitingly, L48Q TnC expressing mice were able to pre-
serve higher contractility, ejection fraction, cardiac performance and decreased
death rate even after undergoing trans-aortic constriction or myocardial in-
farction. Additionally, L48Q TnC was able to increase contractility, ejection
fraction and cardiac performance in mice which expressed L48Q TnC after
having a myocardial infarction. In summary, engineered TnCs show potential
to be used as treatment strategies against different cardiomyopathies.
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Calcium binding to and dissociation from cardiac troponin C (TnC) are essential
steps leading to cardiac muscle contraction/relaxation. It is well documented
that the calcium binding properties of TnC are not constant, but are sensitive to
complex interactions between the additional thin and even thick filament proteins.
There is a growing body of evidence that protein modifications/mutations within
